RPath president Dr Bernie Croal discusses the evolving landscape of pathology in the UK, the challenges and opportunities, ...

A new study highlights the risks of atopic dermatitis flare-ups after discontinuing dupilumab and the likelihood of ...

Dr Urmas Sule details how Estonia weathered the significant challenges of 2022 and his hopes and expectations for 2023.

Further measures to be introduced to highlight risk of neuropsychiatric reactions in patients prescribed montelukast for asthma.

E. coli is capable of turning plastic waste into paracetamol and could offer a new and sustainable production method, says new study.

A new inherited DNA repair deficiency syndrome called DIAL syndrome, which increases blood cancer risk and chemo toxicity has been identified.

Aggressive end-of-life care would appear to be more common among residents within nursing homes compared to those in community dwellings ...

Glyphosate is a commonly used herbicides and a study in farmers observed positive associations with biomarkers of oxidative DNA damage Regular use of the herbicide glyphosate among farmers is ...

Pembrolizumab therapy in patients with high-risk, non-muscle-invasive bladder cancer unresponsive to BCG treatment shows anti-tumour activity Data presented at the 2023 American Society for Clinical ...

A significant five-year overall survival rate has been observed with the use of neoadjuvant nivolumab in resectable non-small cell lung cancer. In the current study, a team from Johns Hopkins Sidney ...

Almost one in 10 doctors in the EU intend to leave their profession, highlighting widespread retention issues, the METEOR Project shows.

Tailoring opioid prescriptions for patients discharged from an emergency department (ED) with acute pain can support recovery and help to avoid the risk of drug misuse, according to a study presented ...